These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 28591789

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Vancomycin Taper and Risk of Failure of Fecal Microbiota Transplantation in Patients With Recurrent Clostridium difficile Infection.
    Patron RL, Hartmann CA, Allen S, Griesbach CL, Kosiorek HE, DiBaise JK, Orenstein R.
    Clin Infect Dis; 2017 Oct 01; 65(7):1214-1217. PubMed ID: 28575220
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Oral teicoplanin versus oral vancomycin for the treatment of severe Clostridium difficile infection: a prospective observational study.
    Popovic N, Korac M, Nesic Z, Milosevic B, Urosevic A, Jevtovic D, Mitrovic N, Markovic A, Jordovic J, Katanic N, Barac A, Milosevic I.
    Eur J Clin Microbiol Infect Dis; 2018 Apr 01; 37(4):745-754. PubMed ID: 29299697
    [Abstract] [Full Text] [Related]

  • 6. OPT-80 eliminates Clostridium difficile and is sparing of bacteroides species during treatment of C. difficile infection.
    Louie TJ, Emery J, Krulicki W, Byrne B, Mah M.
    Antimicrob Agents Chemother; 2009 Jan 01; 53(1):261-3. PubMed ID: 18955523
    [Abstract] [Full Text] [Related]

  • 7. Systematic Review and Meta-Analysis: Efficacy of Vancomycin Taper and Pulse Regimens in Clostridioides difficile Infection.
    Sehgal K, Zandvakili I, Tariq R, Pardi DS, Khanna S.
    Expert Rev Anti Infect Ther; 2022 Apr 01; 20(4):577-583. PubMed ID: 34693838
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical outcomes of fidaxomicin vs oral vancomycin in recurrent Clostridium difficile infection.
    Tieu JD, Williams RJ, Skrepnek GH, Gentry CA.
    J Clin Pharm Ther; 2019 Apr 01; 44(2):220-228. PubMed ID: 30350418
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Fidaxomicin versus vancomycin for Clostridium difficile infection.
    Louie TJ, Miller MA, Mullane KM, Weiss K, Lentnek A, Golan Y, Gorbach S, Sears P, Shue YK, OPT-80-003 Clinical Study Group.
    N Engl J Med; 2011 Feb 03; 364(5):422-31. PubMed ID: 21288078
    [Abstract] [Full Text] [Related]

  • 13. Susceptibility of Clostridium difficile isolates from a Phase 2 clinical trial of cadazolid and vancomycin in C. difficile infection.
    Gerding DN, Hecht DW, Louie T, Nord CE, Talbot GH, Cornely OA, Buitrago M, Best E, Sambol S, Osmolski JR, Kracker H, Locher HH, Charef P, Wilcox M.
    J Antimicrob Chemother; 2016 Jan 03; 71(1):213-9. PubMed ID: 26433782
    [Abstract] [Full Text] [Related]

  • 14. Comparison of oral vancomycin capsule and solution for treatment of initial episode of severe Clostridium difficile Infection.
    Bass SN, Lam SW, Bauer SR, Neuner EA.
    J Pharm Pract; 2015 Apr 03; 28(2):183-8. PubMed ID: 24375999
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A pilot study to assess bacterial and toxin reduction in patients with Clostridium difficile infection given fidaxomicin or vancomycin.
    Thabit AK, Alam MJ, Khaleduzzaman M, Garey KW, Nicolau DP.
    Ann Clin Microbiol Antimicrob; 2016 Apr 12; 15():22. PubMed ID: 27071986
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of alternative fidaxomicin dosing regimens for treatment of simulated Clostridium difficile infection in an in vitro human gut model.
    Chilton CH, Crowther GS, Todhunter SL, Ashwin H, Longshaw CM, Karas A, Wilcox MH.
    J Antimicrob Chemother; 2015 Sep 12; 70(9):2598-607. PubMed ID: 26078392
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.